Innovations in the Delivery of Peptides – Opportunities, challenges, innovations and progress
This article was originally published in Scrip
Executive Summary
The number of therapeutic peptides in clinical study is on the rise, but most are inherently unsuited to simple oral delivery. The success of such drugs will depend to a large extent on the application of innovative delivery techniques, writes Irene Buggle in a new report from Scrip Insights.